Quintiles relocates European headquarters
pharmafile | August 11, 2010 | News story | Research and Development, Sales and Marketing | Quintiles
Contract research organisation and pharma services company Quintiles is moving its European headquarters to Reading in the UK.
Previously based in nearby Bracknell, the company’s new offices will have better travel connections to London and bring together employees from across its business.
Quintiles chairman and chief executive Dr Dennis Gillings said: “Our customers are facing an increasingly complex set of challenges which we refer to as the New Health.
“To help our customers succeed in this new landscape, we are constantly looking at how we can raise our game around team work, customer service and quality – three of our core values. This move to a technologically advanced single site will be a big step forward for our highly talented team and the customers they serve.”
The state of the art facility has been designed and built to the highest sustainability standards, winning strong ratings for energy efficiency and environmental impact.
The investment by follows the opening of its state of the art laboratory and office facility in Edinburgh, Scotland in 2009 and the expansion of its phase I facility in London, which was completed in March 2010.
Dominic Tyer
Related Content

Quintiles to merge with IMS Health
IMS Health (NYSE: IMS) and Quintiles (NYSE: Q) have announced that a definitive merger agreement …
Contract research news in brief
Icon offers $52m for CCH’s clinical services division, plus updates from PPD, Aptuit, Argenta, Quintiles …
Contract research news in brief
Synteract agrees to by Harrison Clinical Research, WuXi forges JV with PR, plus appointments and …






